Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6F0E

Structure of yeast Sec14p with a picolinamide compound

6F0E の概要
エントリーDOI10.2210/pdb6f0e/pdb
分子名称SEC14 cytosolic factor, ~{N}-(1,3-benzodioxol-5-ylmethyl)-5-bromanyl-3-fluoranyl-pyridine-2-carboxamide (3 entities in total)
機能のキーワードsec14p, lipid transfer protein, chemogenomics, target identification, functional variomics, co-crystal, antifungal, benzamide, picolinamide, lipid binding protein
由来する生物種Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
細胞内の位置Golgi apparatus membrane; Peripheral membrane protein: P24280
タンパク質・核酸の鎖数1
化学式量合計36401.02
構造登録者
Hong, Z.,Johnen, P.,Schaaf, G.,Bono, F. (登録日: 2017-11-20, 公開日: 2018-01-17, 最終更新日: 2024-01-17)
主引用文献Pries, V.,Nocker, C.,Khan, D.,Johnen, P.,Hong, Z.,Tripathi, A.,Keller, A.L.,Fitz, M.,Perruccio, F.,Filipuzzi, I.,Thavam, S.,Aust, T.,Riedl, R.,Ziegler, S.,Bono, F.,Schaaf, G.,Bankaitis, V.A.,Waldmann, H.,Hoepfner, D.
Target Identification and Mechanism of Action of Picolinamide and Benzamide Chemotypes with Antifungal Properties.
Cell Chem Biol, 25:279-290.e7, 2018
Cited by
PubMed Abstract: Invasive fungal infections are accompanied by high mortality rates that range up to 90%. At present, only three different compound classes are available for use in the clinic, and these often suffer from low bioavailability, toxicity, and drug resistance. These issues emphasize an urgent need for novel antifungal agents. Herein, we report the identification of chemically versatile benzamide and picolinamide scaffolds with antifungal properties. Chemogenomic profiling and biochemical assays with purified protein identified Sec14p, the major phosphatidylinositol/phosphatidylcholine transfer protein in Saccharomyces cerevisiae, as the sole essential target for these compounds. A functional variomics screen identified resistance-conferring residues that localized to the lipid-binding pocket of Sec14p. Determination of the X-ray co-crystal structure of a Sec14p-compound complex confirmed binding in this cavity and rationalized both the resistance-conferring residues and the observed structure-activity relationships. Taken together, these findings open new avenues for rational compound optimization and development of novel antifungal agents.
PubMed: 29307839
DOI: 10.1016/j.chembiol.2017.12.007
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.6 Å)
構造検証レポート
Validation report summary of 6f0e
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon